Meta-analysis for rare events
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Meta-analysis provides a useful framework for combining information across related studies and has been widely utilized to combine data from clinical studies in order to evaluate treatment efficacy. More recently, meta-analysis has also been used to assess drug safety. However, because adverse events are typically rare, standard methods may not work well in this setting. Most popular methods use fixed or random effects models to combine effect estimates obtained separately for each individual study. In the context of very rare outcomes, effect estimates from individual studies may be unstable or even undefined. We propose alternative approaches based on Poisson random effects models to make inference about the relative risk between two treatment groups. Simulation studies show that the proposed methods perform well when the underlying event rates are low. The methods are illustrated using data from a recent meta-analysis (N. Engl. J. Med. 2007; 356(24):2457-2471) of 48 comparative trials involving rosiglitazone, a type 2 diabetes drug, with respect to its possible cardiovascular toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675 · cited 5×
“For example, Nissen and Wolski [1] evaluated the effect of rosiglitazone, a type 2 diabetes drug, with respect to the risk of myocardial infarction (MI) and CVD-related death.”
InfluentialBeta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205 · cited 1×
“When data can be arrayed as a set of multiple 2×2 tables, the most commonly used procedures include the Mantel–Haenszel (MH) [3] and Peto methods [4].”
MethodCox, D. R., & Hinkley, D. V. (1974) · doi:10.1007/978-1-4899-2887-0 · Cited by 3,089
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938 · cited 2×
“This raises the concern of applying arbitrary imputations, which has been noted in existing studies [5, 6].”
BackgroundResultMurphy, S. A., & Van Der Vaart, A. W. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10474219 · Cited by 712 · cited 1×
“Alternatively, one may construct confidence intervals for a specific component of h based on the profile likelihood theory [18, 19].”
Cited by
Bias caused by sampling error in meta-analysis with small sample sizes
Lin, L. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204056 · Cited by 335
Meta-analysis: pitfalls and hints.
(2013) · Europe PMC (PubMed Central) · Cited by 298
Bryant, A., Lawrie, T. A., Dowswell, T., Fordham, E. J., Mitchell, S., Hill, S. R., & Tham, T. C. (2021) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001402 · Cited by 264
Practical guide to the meta-analysis of rare events
Efthimiou, O. (2018) · Evidence Based Mental Health · doi:10.1136/eb-2018-102911 · Cited by 231
Kuss, O. (2015) · Statistics in Medicine · doi:10.1002/sim.6383 · Cited by 206
Metadata
- Authors
- Cai, T., Parast, L., & Ryan, L.
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 2010-07-11
- Volume
- 29
- Issue
- 20
- Pages
- 2078-2089
- ISSN
- 0277-6715 (ISSN-L)
- OpenAlex
- W2114011456
- Cited by
- 110
- References
- 5
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.